Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

COVID-19 vaccine hesitancy rates remain high 

By Brian Buntz | February 11, 2021

Image courtesy of Unsplash

While estimates vary, achieving herd immunity against COVID-19 will likely require vaccinating at least 70% to 80% of the public, if not more. Some diseases, like measles, require a vaccination rate of 95%, according to the World Health Organization.

Yet, many people in the U.S. public remains guarded about COVID-19 vaccines. Almost one out of three Americans say they definitely or probably wouldn’t get vaccinated, according to a recent survey from The Associated Press-NORC Center for Public Affairs Research. A total of 15% were certain they wouldn’t get vaccinated.

Kaiser Family Foundation research from December found that 27% of the public remains vaccine-hesitant.

A survey from late last year found that 58% of adults aged 50 to 80 would be somewhat or very likely to get a COVID-19 vaccine.

Ultimately, vaccine hesitancy could be a bigger challenge to herd immunity than the current vaccine shortfalls, argued Dr. Scott Gottlieb, former FDA commissioner, in The Wall Street Journal. By April, it is possible that “supply will start exceeding demand,” Gottlieb wrote. “The challenge won’t be how to ration a scarce resource, but how to reach patients reluctant to get vaccinated.”

The most common reason for the reluctance is concern about COVID-19 vaccines’ safety and efficacy. Some 59% of people who are vaccine-hesitant worry about side effects.

Vaccine misinformation is also rampant. Facebook recently announced plans to crack down on false information related to COVID-19 vaccines.

There is, however, reason for optimism. Attitudes toward vaccines are improving in many parts of the world, according to Nature.

About The Author

Brian Buntz

The pharma and biotech editor of WTWH Media, Brian is a veteran journalist with more than 15 years of experience covering an array of life science topics, including clinical trials, drug discovery and development and medical devices. Before coming to WTWH, he served as content director focused on connected devices at Informa. In addition, Brian covered the medical device sector for 10 years at UBM. At Qmed, he overhauled the brand’s news coverage and helped to grow the site’s traffic volume dramatically. He had previously held managing editor roles on two of the company’s medical device technology publications. Connect with him on LinkedIn or email at [email protected].

Comments

  1. Kelly Thomas says

    February 17, 2021 at 12:04 am

    I got the Moderna vaccine. The second shot worked me over, headache, body aches, temperature and nauseated. If you want me to ever take another one, the side effects must be minimized.

    Reply
  2. KMBNette says

    February 17, 2021 at 4:19 pm

    I got the second dose of the Pfizer vaccine yesterday and aside from a sore arm this morning and some chills and tiredness late last night, side effects seem to be minimal. Everyone’s immune system is different, so they may get slightly different reactions, but it seems that the side effects are insignificant compared to getting severe COVID.

    Reply

Tell Us What You Think! Cancel reply

Related Articles Read More >

This is the logo of Novartis.
Novartis breaks ground on North Carolina facility
AstraZeneca
AstraZeneca to invest $2B in Maryland, support 2,600 jobs
This is the logo of Novartis.
Novartis opens new manufacturing plant in California
samsung biologics (1)
Samsung Biologics completes Bioepis spinoff to become pure-play pharma CDMO
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE